Cargando…

Link between plasminogen activator inhibitor-1 and cardiovascular risk in chronic hepatitis C after viral clearance

The pathophysiological implications of plasminogen activator inhibitor-1 (PAI-1) in HCV infection remain obscure. This prospective study evaluated 669 HCV patients, of whom 536 had completed a course of anti-HCV therapy and had pre-, peri- and post-therapy measurements of various profiles, including...

Descripción completa

Detalles Bibliográficos
Autores principales:	Chang, Ming-Ling, Lin, Yu-sheng, Pao, Li-Heng, Huang, Hsin-Chih, Chiu, Cheng-Tang
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group 2017
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5304196/ https://www.ncbi.nlm.nih.gov/pubmed/28211910 http://dx.doi.org/10.1038/srep42503

Ejemplares similares

Association between Leptin and Complement in Hepatitis C Patients with Viral Clearance: Homeostasis of Metabolism and Immunity
por: Chang, Ming-Ling, et al.
Publicado: (2016)

Distinct Patterns of the Lipid Alterations between Genotype 1 and 2 Chronic Hepatitis C Patients after Viral Clearance
por: Chang, Ming-Ling, et al.
Publicado: (2014)

The Evolving Interplay among Abundant Adipokines in Patients with Hepatitis C during Viral Clearance
por: Chang, Ming-Ling, et al.
Publicado: (2017)

Accelerated cardiovascular risk after viral clearance in hepatitis C patients with the NAMPT-rs61330082 TT genotype: An 8-year prospective cohort study
por: Chang, Ming-Ling, et al.
Publicado: (2021)

Decoupled Glucose and Lipid Metabolic Recovery after Viral Clearance in Direct-Acting Antiviral-Treated HCV Patients: A 3-Year Prospective Cohort Study
por: Lee, Heng, et al.
Publicado: (2021)

Hypozincemia in Chronic Hepatitis C Is Improved with Viral Clearance by Direct-acting Antiviral Agents
por: Shirahashi, Ryosaku, et al.
Publicado: (2021)

Relationship between tissue plasminogen activator, plasminogen activator inhibitor and CT image in chronic subdural hematoma.
por: Lim, D. J., et al.
Publicado: (1995)

Novel Small-Molecule Inhibitors of Hepatitis C Virus Entry Block Viral Spread and Promote Viral Clearance in Cell Culture
por: Coburn, Glen A., et al.
Publicado: (2012)

Spontaneous hepatitis C viral clearance and hepatitis C chronic infection are associated with distinct cytokine profiles in Mexican patients
por: Fierro, Nora A, et al.
Publicado: (2015)

Chronic Viral Hepatitis and Metabolic Syndrome/Cardiovascular Risk
por: Jarcuska, Peter, et al.
Publicado: (2018)

Restoring Inflammatory Mediator Balance after Sofosbuvir-Induced Viral Clearance in Patients with Chronic Hepatitis C
por: Saraiva, Geórgia Nascimento, et al.
Publicado: (2018)

Cardiovascular-renal complications and the possible role of plasminogen activator inhibitor: a review
por: D'Elia, John A., et al.
Publicado: (2016)

Localization of Urokinase‐type Plasminogen Activator, Plasminogen Activator Inhibitor‐1, 2 and Plasminogen in Colon Cancer
por: Naitoh, Hiroyuki, et al.
Publicado: (1995)

Predictors of spontaneous viral clearance and outcomes of acute hepatitis C infection
por: Cho, Yoo-Kyung, et al.
Publicado: (2014)

Plasminogen activator inhibitor-1 is elevated in patients with COPD independent of metabolic and cardiovascular function
por: Waschki, Benjamin, et al.
Publicado: (2017)

Circadian rhythm of plasminogen activator inhibitor-1 and cardiovascular complications in type 2 diabetes
por: Yu, Yongzhuo, et al.
Publicado: (2023)

Early hepatitis B viral DNA clearance predicts treatment response at week 96
por: Fu, Xiao-Yu, et al.
Publicado: (2017)

Determinants of Viral Clearance and Persistence during Acute Hepatitis C Virus Infection
por: Thimme, Robert, et al.
Publicado: (2001)

Astrocytes regulate the balance between plasminogen activation and plasmin clearance via cell-surface actin
por: Briens, Aurélien, et al.
Publicado: (2017)

Tissue Plasminogen Activator and Plasminogen Activator Inhibitor 1 Contribute to Sonic Hedgehog-Induced In Vitro Cerebral Angiogenesis
por: Teng, Hua, et al.
Publicado: (2012)

Intact Dendritic Cell Pathogen-Recognition Receptor Functions Associate with Chronic Hepatitis C Treatment-Induced Viral Clearance
por: Rodrigue-Gervais, Ian Gaël, et al.
Publicado: (2014)

The effects of residual platelets in plasma on plasminogen activator inhibitor-1 and plasminogen activator inhibitor-1-related assays
por: Pieters, Marlien, et al.
Publicado: (2017)

Thrombin and plasmin generation in patients with plasminogen or plasminogen activator inhibitor type 1 deficiency
por: Saes, Joline L., et al.
Publicado: (2019)

Risk of hepatitis C virus related hepatocellular carcinoma between subjects with spontaneous and treatment-induced viral clearance
por: Huang, Chung-Feng, et al.
Publicado: (2017)

Endoplasmic reticulum stress induces hepatic plasminogen activator inhibitor 1 in murine nonalcoholic steatohepatitis
por: Olivares, Shantel, et al.
Publicado: (2020)

Two-stage exchange Arthroplasty for knee Periprosthetic joint infection exhibit high infection recurrence rate in patients with chronic viral hepatitis
por: Chen, Jui-ping, et al.
Publicado: (2021)

Plasminogen Activator Inhibitor-1 Protects Mice Against Cardiac Fibrosis by Inhibiting Urokinase-type Plasminogen Activator-mediated Plasminogen Activation
por: Gupta, Kamlesh K., et al.
Publicado: (2017)

Involvement of the Serine Protease Inhibitor, SERPINE2, and the Urokinase Plasminogen Activator in Cumulus Expansion and Oocyte Maturation
por: Lu, Chung-Hao, et al.
Publicado: (2013)

Chronic alcohol abuse and spontaneous clearance of hepatitis C virus
por: Pott, Henrique, et al.
Publicado: (2019)

Retraction: The effects of residual platelets in plasma on plasminogen activator inhibitor-1 and plasminogen activator inhibitor-1-related assays
Publicado: (2018)

Vitamin D Deficiency is Associated With Increased Plasminogen Activator Inhibitor 1/Plasminogen Activator Inhibitor 2 Ratio in Pregnancy
por: Andersen, Matilde Kanstrup, et al.
Publicado: (2023)

New noninvasive index for predicting liver fibrosis in Asian patients with chronic viral hepatitis
por: Wang, Hung-Wei, et al.
Publicado: (2017)

Sociodemographic and clinical characteristics of persons who experienced spontaneous hepatitis C viral clearance
por: Kimble, Mabel Michille, et al.
Publicado: (2019)

Rhinovirus‐16 induced temporal interferon responses in nasal epithelium links with viral clearance and symptoms
por: Ravi, Abilash, et al.
Publicado: (2019)

Tissue Plasminogen Activator and Plasminogen Activator Inhibitor-1 Levels in Patients with Acute Paraquat Intoxication
por: Seok, Su-Jin, et al.
Publicado: (2011)

Structural basis of specific inhibition of tissue-type plasminogen activator by plasminogen activators inhibitor-1
por: Gong, Lihu, et al.
Publicado: (2016)

Role of tissue-type plasminogen activator and plasminogen activator inhibitor-1 in psychological stress and depression
por: Tsai, Shih-Jen
Publicado: (2017)

Plasma tissue plasminogen activator and plasminogen activator inhibitor-1 in hospitalized COVID-19 patients
por: Zuo, Yu, et al.
Publicado: (2021)

Hepatitis C Virus Clearance with Glucose Improvement and Factors Affecting the Glucose Control in Chronic Hepatitis C Patients
por: Yuan, Man, et al.
Publicado: (2020)

Functional Stability of Plasminogen Activator Inhibitor-1
por: Yasar Yildiz, Songul, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_jt6phvvbu4dc55rqeig0rsi3v4